PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.\', \'United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.\', \'Light Imaging Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA.\', \'Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.\', \'Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/infdis/jiaa789
?:doi
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33367731
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all